Future perspectives of circulating tumor DNA in colorectal cancer
Tumor biopsy is currently the gold standard for diagnosis and in determining cell signaling pathways involved in the development of treatment resistance. However, there are major challenges with this technique, including the need for serial sampling to monitor treatment resistance, which is invasive...
Saved in:
| Main Authors: | C Nadal, T Winder, A Gerger, David Tougeron |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-05-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317705749 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer
by: Justin C. Brown, et al.
Published: (2025-12-01) -
Circulating tumor DNA in colorectal cancer: biology, methods and applications
by: Han Chen, et al.
Published: (2025-04-01) -
Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives
by: Yi Wang, et al.
Published: (2025-07-01) -
THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE
by: M. I. Sluzhev, et al.
Published: (2021-10-01) -
Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications
by: Dening Ma, et al.
Published: (2025-06-01)